Position in AMGN
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$2,911,444
+$76,941 QoQ
Shares Held
8,040
-0.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#1,090
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Joel Isaacson & Co., LLC holds $52,580,622 across 13 Drug Manufacturers - General names. AMGN ranks #4 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
79,396 | $20,164,202 | |
| 2 | LLY |
ELI LILLY & Co
|
11,698 | $14,030,933 | |
| 3 | MRK |
Merck & Co., Inc.
|
43,718 | $5,617,763 | |
| 4 | AMGN |
Amgen Inc
This page
|
8,040 | $2,911,444 | |
| 5 | ABBV |
AbbVie Inc.
|
8,694 | $2,187,758 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
37,637 | $2,168,643 | |
| 7 | PFE |
Pfizer Inc
|
86,319 | $2,078,561 | |
| 8 | NVS |
Novartis AG
|
6,486 | $1,016,485 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,911,444 | 8,040 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $2,834,503 | 8,056 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $2,629,935 | 8,035 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $2,257,035 | 7,998 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $1,730,543 | 6,198 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $1,884,565 | 6,049 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $1,576,611 | 6,049 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $1,949,048 | 6,049 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $1,985,619 | 6,355 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $1,806,853 | 6,355 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $1,343,325 | 4,664 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $1,233,877 | 4,591 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $1,019,293 | 4,591 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $1,098,028 | 4,542 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $1,192,910 | 4,542 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $1,023,766 | 4,542 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $859,335 | 3,532 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $854,108 | 3,532 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $797,743 | 3,546 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $755,332 | 3,552 | Shares | Sole | 2021-10-21 | |
| 2021-06-30 | $863,118 | 3,541 | Shares | Sole | 2021-07-20 | |
| 2021-03-31 | $835,255 | 3,357 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $771,841 | 3,357 | Shares | Sole | 2021-01-22 | |
| 2020-09-30 | $886,255 | 3,487 | Shares | Sole | 2020-10-14 | |
| 2020-06-30 | $800,980 | 3,396 | Shares | Sole | 2020-07-21 | |
| 2020-03-31 | $678,942 | 3,349 | Shares | Sole | 2020-04-21 | |
| No filing history on record for this holder in this stock. | ||||||